Comparative Metabolomics and Microbiome Analysis of Ethanol versus OMNImet/gene•GUT Fecal StabilizationShow others and affiliations
2024 (English)In: Analytical Chemistry, ISSN 0003-2700, E-ISSN 1520-6882, Vol. 96, no 22, p. 8893-9304Article in journal (Refereed) Published
Abstract [en]
Metabolites from feces provide important insights into the functionality of the gut microbiome. As immediate freezing is not always feasible in gut microbiome studies, there is a need for sampling protocols that provide the stability of the fecal metabolome and microbiome at room temperature (RT). Here, we investigated the stability of various metabolites and the microbiome (16S rRNA) in feces collected in 95% ethanol (EtOH) and commercially available sample collection kits with specific preservatives OMNImet•GUT/OMNIgene•GUT. To simulate field-collection scenarios, the samples were stored at different temperatures at varying durations (24 h + 4 °C, 24 h RT, 36 h RT, 48 h RT, and 7 days RT) and compared to aliquots immediately frozen at -80 °C. We applied several targeted and untargeted metabolomics platforms to measure lipids, polar metabolites, endocannabinoids, short-chain fatty acids (SCFAs), and bile acids (BAs). We found that SCFAs in the nonstabilized samples increased over time, while a stable profile was recorded in sample aliquots stored in 95% EtOH and OMNImet•GUT. When comparing the metabolite levels between aliquots stored at room temperature and at +4 °C, we detected several changes in microbial metabolites, including multiple BAs and SCFAs. Taken together, we found that storing samples at RT and stabilizing them in 95% EtOH yielded metabolomic results comparable to those from flash freezing. We also found that the overall composition of the microbiome did not vary significantly between different storage types. However, notable differences were observed in the α diversity. Altogether, the stability of the metabolome and microbiome in 95% EtOH provided results similar to those of the validated commercial collection kits OMNImet•GUT and OMNIgene•GUT, respectively.
Place, publisher, year, edition, pages
American Chemical Society (ACS), 2024. Vol. 96, no 22, p. 8893-9304
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-113821DOI: 10.1021/acs.analchem.3c04436ISI: 001231838700001PubMedID: 38782403Scopus ID: 2-s2.0-85194148364OAI: oai:DiVA.org:oru-113821DiVA, id: diva2:1860357
Funder
Academy of Finland, 323171; 333981Swedish Research Council, 2016-05176Swedish Research Council Formas, 2019-00869Novo Nordisk Foundation, NNF20OC0063971
Note
This study was supported by the National Institute on Health grant (U19AG063744; PI: Kaddurdah-Daouk) and the Academy of Finland project grant, (No. 323171 to S.L.), (No. 333981 to M.O.), Swedish Research Council (Grant No. 2016-05176 to T.H. and M.O.), Formas (Grant No. 2019-00869 to T.H. and M.O.), and the Novo Nordisk Foundation (Grant No. NNF20OC0063971 to T.H. and M.O.). Further support was received from "Inflammation in human early life: targeting impacts on life-course health" (INITIALISE) consortium funded by the Horizon Europe Program of the European Union under Grant Agreement 101094099 (to M.O. and T.H.) and Alzheimer's Gut Microbiome Project (https://alzheimergut.org/). A.A. and H.I. were supported by the Signe and Ane Gyllenberg Foundation (grant no. 6273). H.I. received funding from the Finnish Cultural Foundation (grant no. 00230482) and further supported by the Doctoral Program in Clinical Research at the University of Turku.
2024-05-242024-05-242024-06-14Bibliographically approved